RAMM Pharma Corp.

C$0.01As of Sun 8 Nov 2026, 12:00 UTC

CSE:RAMMHealthcare

Country Canada

PE (Fwd) •••

TSR 7Y CAGR (40.49%)

Div yield —

ROE (112.44%)

Drug Manufacturers (Specialty & Generic)

Beta (5Y) 0.44

PE TTM —

TSR TTM —

Mkt cap C$1.791M

ROIC (32.51%)

SE Grade™

Value

Quality

Moat

Consensus

Reference

$0.0192

27.99%

203.48%

Hold 9|2|3|10|4

TTM

FYE 31 Oct CAD

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026E

FY2027E

Trend

5Y

10Y

Peers

0.624

Revenue$M

0.280

0.304

0.325

0.353

0.391

0.421

0.462

0.508

0.553

0.663

0.665

9.42%

8.76%

40

15.56

Revenue growth%

7.75

6.84

9.60

11.19

14.15

14.56

11.86

11.55

9.25

17.60

27.01

11.86

10.39

61

23.53

Gross margin%

4.31

4.60

5.78

5.47

7.99

10.31

11.31

9.13

11.04

26.96

18.56

10.31

6.88

80

20.45

Operating margin%

0.40

0.40

2.09

0.40

0.86

0.40

2.14

1.22

3.80

26.04

20.30

1.22

0.63

76

11.93

Net margin%

25.30

27.89

28.33

30.44

29.58

30.00

27.08

25.09

24.96

15.83

24.20

27.08

27.48

7

36.19

P/E ratio (avg)x

32.31

35.68

37.78

39.83

41.79

39.58

37.26

36.07

40.42

14.37

8.936

39.58

37.52

63

29.88

EV/EBITx

37.77

40.61

39.67

41.93

44.31

44.02

38.08

36.17

36.11

8.326

36.65

38.08

38.88

12

14.24

FCF yield (avg)%

24.17

25.64

23.00

20.41

19.52

17.28

16.72

16.10

13.38

12.09

7.11

16.72

19.97

10

5.99

FCF margin%

2.39

3.33

1.21

2.39

2.49

0.40

3.28

2.98

1.30

14.98

26.27

2.49

2.44

22

0.668

FCF / Net incomex

1.412

1.493

1.555

1.580

1.709

1.534

1.413

1.273

1.315

1.739

1.629

1.413

1.453

11

2.84

ROIC%

17.25

15.52

13.60

10.71

13.68

15.66

17.17

18.67

19.16

24.29

30.00

17.17

15.59

55

5.01

Return on equity%

30.29

30.69

30.97

28.04

25.63

24.87

23.40

26.29

25.80

11.16

29.08

25.63

26.98

78

5.65

Return on assets%

8.59

6.07

5.25

4.50

4.88

2.48

4.96

7.72

5.91

18.20

8.64

4.96

5.58

21

—

EPS$

—

—

—

—

—

—

—

—

—

—

—

1.31%

0.26%

—

2.54

EPS growth%

2.72

0.40

3.40

6.21

6.88

6.07

4.35

2.40

3.70

25.11

27.36

4.35

4.03

90

—

Bookvalue per sh$

—

—

—

—

—

—

—

—

—

—

—

8.54%

7.31%

—

—

FCF per share$

—

—

—

—

—

—

—

—

—

—

—

(1.14%)

1.51%

—

—

Dividend per sh$

—

—

—

—

—

—

—

—

—

—

—

(0.91%)

(0.92%)

—

13.91

Div yield (avg)%

22.42

19.70

19.17

19.47

21.92

24.68

24.01

24.05

25.82

10.62

27.40

24.05

22.17

41

24.85

Payout ratio%

4.40

5.22

4.74

4.64

2.62

4.21

1.41

2.53

4.33

21.95

6.57

2.62

4.36

79

118.2

Shares (diluted)M

92.94

100.1

104.1

93.71

98.54

93.14

81.76

77.06

75.67

122.0

121.8

(4.19%)

(1.69%)

44

11.23

Buyback yield%

16.17

14.07

13.61

15.17

13.67

11.15

10.18

10.93

9.81

24.87

26.15

10.93

13.64

74

1.161

D/E ratiox

0.424

0.379

0.376

0.410

0.391

0.409

0.402

0.389

0.363

0.424

0.234

0.391

0.396

60

0.596

Enterprise value$M

0.590

0.631

0.586

0.536

0.499

0.520

0.472

0.494

0.482

0.404

0.093

(2.12%)

(3.24%)

95

0.467

LT debt$M

0.455

0.464

0.476

0.427

0.467

0.419

0.392

0.427

0.410

0.658

0.426

(0.83%)

(2.45%)

26

Peers (US$1.268M)

Cap (US$)

PE

Copland Road Capital…

1.388M

—

CordovaCann Corp.

1.096M

—

IM Cannabis Corp.

1.051M

—

Gabather AB (publ)

1.271M

—

Capital

TTM

5Y

10Y

Leveragex

0.484

0.301

0.276

EBIT/Intx

11.33

0.327

0.248

Own earn%

(83.58)

115.37

100.98

Sh yield%

25.14

35.59

34.81

Owners

Insiders/Inst%

7.12

52.80

Short interest%

6.00

SBC / revenue%

2.85

Record

10Y

Profitable years

10/10

Revenue growth years

10/10

EPS growth years

10/10

Dividend streakyrs

2

Op margin range%

0–4

$1 testx

—

Incr. ROIC%

5

Growth vs revenue

Latest

Trend

10Y CAGR

Rel growth

Revenue

$0.553M

8.76%

1.00×

Cost of revenue

$0.271M

8.87%

1.01×

Operating expenses

$0.116M

9.09%

1.03×